An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

Clinical trial NCT00263068 · COMPLETED

Trial details

NCT number: NCT00263068
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Restless Legs Syndrome

Start date: 2005-12-01
Primary completion: 2007-12-01
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.